UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

The New England journal of medicine, 1992-12, Vol.327 (23), p.1618-1624

1992

Volltextzugriff (PDF)

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure

Journal of clinical oncology, 1992-02, Vol.10 (2), p.210-218

1992

Volltextzugriff (PDF)

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine

Journal of clinical oncology, 1996-03, Vol.14 (3), p.806-813

1996

Volltextzugriff (PDF)

Obesity and Therapy-Related Toxicity in Patients Treated for Small-Cell Lung Cancer

JNCI : Journal of the National Cancer Institute, 1995-03, Vol.87 (5), p.361-366

1995

Volltextzugriff (PDF)

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer

Journal of clinical oncology, 1994-10, Vol.12 (10), p.2022-2034

1994

Volltextzugriff (PDF)

Chemotherapy of Lung Cancer

The New England journal of medicine, 1992-11, Vol.327 (20), p.1434-1441

Ihde, Daniel C

1992

Volltextzugriff (PDF)

Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers

Annals of internal medicine, 1993-09, Vol.119 (5), p.383

1993

Volltextzugriff (PDF)

Small cell lung cancer : state-of-the-art therapy 1994

Chest, 1995-06, Vol.107 (6), p.243S-248S

IHDE, D. C

1995

Volltextzugriff (PDF)

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

The New England journal of medicine, 1989-12, Vol.321 (26), p.1784-1790

1989

Volltextzugriff (PDF)

Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease

Journal of clinical oncology, 1997-11, Vol.15 (11), p.3338-3346

1997

Volltextzugriff (PDF)

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors

Journal of clinical oncology, 1988-06, Vol.6 (6), p.1031-1040

1988

Volltextzugriff (PDF)

myc Family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course

The Journal of clinical investigation, 1987-06, Vol.79 (6), p.1629-1634

1987

Volltextzugriff (PDF)

Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing

Clinical cancer research, 1997-05, Vol.3 (5), p.741-747

1997

Volltextzugriff (PDF)

Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome

Journal of clinical oncology, 1992-12, Vol.10 (12), p.1907-1913

1992

Volltextzugriff (PDF)

Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial

Journal of clinical oncology, 1991-01, Vol.9 (1), p.25-38

1991

Volltextzugriff (PDF)

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups

Annals of internal medicine, 1988-09, Vol.109 (5), p.372

1988

Volltextzugriff (PDF)

Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute

Mayo Clinic proceedings, 1997-10, Vol.72 (10), p.901-912

1997

Volltextzugriff (PDF)

Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management

Journal of clinical oncology, 1988-12, Vol.6 (12), p.1832-1837

1988

Volltextzugriff (PDF)

Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome

Journal of clinical oncology, 1994-10, Vol.12 (10), p.2051-2059

1994

Volltextzugriff (PDF)

Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532

Lung cancer (Amsterdam, Netherlands), 2000-04, Vol.28 (1), p.63-68

2000

Volltextzugriff (PDF)

MDR1 Gene Expression in Lung Cancer

JNCI : Journal of the National Cancer Institute, 1989-08, Vol.81 (15), p.1144-1150

1989

Volltextzugriff (PDF)

The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment

Seminars in hematology, 1988-04, Vol.25 (2 Suppl 2), p.11

1988

Volltextzugriff (PDF)

Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium

Cancer research (Chicago, Ill.), 1993, Vol.53 (1), p.67-74

1993

Volltextzugriff (PDF)

Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy

Journal of clinical oncology, 1989-09, Vol.7 (9), p.1295-1302

1989

Volltextzugriff (PDF)

Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas

Annals of internal medicine, 1984-10, Vol.101 (4), p.484

1984

Volltextzugriff (PDF)

1 – 25 von 223

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(147)

Publikationsform

Sprache

Englisch
(218)
Französisch
(5)

Erscheinungsjahr

n.n

Thema

Humans
(180)
Science & Technology
(144)
Life Sciences & Biomedicine
(141)
Male
(105)
Female
(93)
Oncology
(92)
Middle Aged
(88)
Aged
(72)
Lung Neoplasms - Drug Therapy
(66)
Adult
(63)
Biological And Medical Sciences
(60)
Medical Sciences
(59)
Carcinoma, Small Cell - Drug Therapy
(57)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(49)
Lung Neoplasms - Pathology
(40)
Combined Modality Therapy
(37)
Prognosis
(34)
Lung Neoplasms - Therapy
(32)
Carcinoma, Small Cell - Pathology
(31)
Lung Neoplasms - Mortality
(31)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

A Meta-Analysis of Thoracic Radiotherapy for Small-Cell Lung Cancer

Conventional-dose salvage combination chemotherapy in patients relapsing with Hodgkin's disease after combination chemotherapy: the low probability for cure

Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine

Obesity and Therapy-Related Toxicity in Patients Treated for Small-Cell Lung Cancer

Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer

Chemotherapy of Lung Cancer

Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers

Small cell lung cancer : state-of-the-art therapy 1994

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease

A randomized trial of standard chemotherapy v a high-dose chemotherapy regimen in the treatment of poor prognosis nonseminomatous germ-cell tumors

myc Family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course

Survival of patients with limited-stage small cell lung cancer treated with individualized chemotherapy selected by in vitro drug sensitivity testing

Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome

Superiority of ProMACE-CytaBOM over ProMACE-MOPP in the treatment of advanced diffuse aggressive lymphoma: results of a prospective randomized trial

Histopathologic staging at initial diagnosis of mycosis fungoides and the Sézary syndrome. Definition of three distinctive prognostic groups

Outcome of patients with small-cell lung cancer during 20 years of clinical research at the US National Cancer Institute

Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management

Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome

Paclitaxel/ifosfamide or navelbine/ifosfamide chemotherapy for advanced non-small cell lung cancer: CALGB 9532

MDR1 Gene Expression in Lung Cancer

The treatment of indolent lymphomas: watchful waiting v aggressive combined modality treatment

Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium

Treatment of localized aggressive lymphomas with combination chemotherapy followed by involved-field radiation therapy

Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas

Suchergebnisse filtern